{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T10:21:44Z","timestamp":1697278904507},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Respir Med"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1007\/bf03256607","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T03:44:22Z","timestamp":1345693462000},"page":"177-183","source":"Crossref","is-referenced-by-count":6,"title":["Peptide Receptor Imaging"],"prefix":"10.1007","volume":"1","author":[{"given":"Christophe","family":"Van de Wiele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Signore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi Andre","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,20]]},"reference":[{"key":"BF03256607_CR1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s002590100583","volume":"28","author":"A Signore","year":"2001","unstructured":"Signore A, Annovazzi A, Chianelli M, et al. Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 2001; 28: 1555\u201365","journal-title":"Eur J Nucl Med"},{"key":"BF03256607_CR2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/cr980436l","volume":"9","author":"S Liu","year":"1999","unstructured":"Liu S, Edwards DS. 99mTc-labelled small peptides as diagnostic radiopharmaceuticals. Chem Rev 1999; 9: 2235\u201368","journal-title":"Chem Rev"},{"key":"BF03256607_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0038-1625644","volume":"41","author":"TM Behr","year":"2002","unstructured":"Behr TM, Gotthardt M, Becker W, et al. Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy: a review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen\/Marburg Experience. Nuklearmedizin 2002; 41: 71\u20139","journal-title":"Nuklearmedizin"},{"key":"BF03256607_CR4","first-page":"189","volume":"45","author":"TM Behr","year":"2001","unstructured":"Behr TM, Gotthardt M, Barth A, et al. Imaging tumors with peptide-based radiopharmaceuticals. Q J Nucl Med 2001; 45: 189\u2013200","journal-title":"Q J Nucl Med"},{"key":"BF03256607_CR5","first-page":"260","volume-title":"The molecular basis of cancer","author":"MJ Kelley","year":"2001","unstructured":"Kelley MJ, Johnson BE. Molecular biology of lung cancer. In: Mendelsohn J, Howley PM, Israel MA, et al., editors. The molecular basis of cancer. Philadelphia (PA): Saunders, 2001: 260\u201372"},{"key":"BF03256607_CR6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0024-3205(93)90098-N","volume":"52","author":"TW Moody","year":"1993","unstructured":"Moody TW, Cuttita F. Growth-factor and peptide receptors in small-cell lung cancer. Life Sci 1993; 52: 1161\u201373","journal-title":"Life Sci"},{"key":"BF03256607_CR7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0196-9781(95)02148-5","volume":"17","author":"TW Moody","year":"1996","unstructured":"Moody TW. Peptides and growth factors in non-small cell lung cancer. Peptides 1996; 17: 545\u201355","journal-title":"Peptides"},{"key":"BF03256607_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1040-8428(99)00004-9","volume":"31","author":"A Ardizzonni","year":"1999","unstructured":"Ardizzonni A, Grossi F, Meazza R, et al. New perspectives for the pharmacological and biological therapy of small cell lung cancer. Crit Rev Oncol Hematol 1999; 31: 135\u201345","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF03256607_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.112.4_Supplement.266S","volume":"4","author":"E Frei","year":"1997","unstructured":"Frei E. Non-small cell lung cancer: novel treatment strategies. Chest 1997; 4 Suppl.: 266\u20138","journal-title":"Chest"},{"key":"BF03256607_CR10","volume-title":"U.S. Patent","author":"ER Spindel","year":"1995","unstructured":"Spindel ER, Nagalla S, Barry B. Bombesin-related peptides. U.S. Patent 1995, 5,410,018"},{"key":"BF03256607_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-291X(79)91614-0","volume":"90","author":"TJ McDonald","year":"1979","unstructured":"McDonald TJ, Jornvall H, Nilsson G, et al. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 1979; 90: 227\u201333","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03256607_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00006231-200101000-00002","volume":"1","author":"C Wiele Van de","year":"2001","unstructured":"Van de Wiele C, Dumont F, Van Belle S, et al. Is there a role for agonist gastrin releasing peptide receptor radioligands in tumour imaging? Nucl Med Commun 2001; 1: 5\u201315","journal-title":"Nucl Med Commun"},{"issue":"3","key":"BF03256607_CR13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0169-5002(95)00597-8","volume":"15","author":"M ToiScott","year":"1996","unstructured":"ToiScott M, Jones CL, Kane MA. Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells. Lung Cancer 1996; 15(3): 341\u201354","journal-title":"Lung Cancer"},{"key":"BF03256607_CR14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0016-5085(97)70131-8","volume":"112","author":"JC Reubi","year":"1997","unstructured":"Reubi JC, Waser B, Laderach U, et al. Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach. Gastroenterology 1997; 112: 1197\u2013205","journal-title":"Gastroenterology"},{"key":"BF03256607_CR15","first-page":"1377","volume":"57","author":"JC Reubi","year":"1997","unstructured":"Reubi JC, Schaer JC, Waser B. Cholecystokinin (CCK)-A and CCK-B\/gastrin receptors in human tumors. Cancer Res 1997; 57: 1377\u201386","journal-title":"Cancer Res"},{"key":"BF03256607_CR16","first-page":"3124","volume":"10","author":"TM Behr","year":"1999","unstructured":"Behr TM, Behe M, Angerstein C, et al. CholecystokininB\/gastrin receptors binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Clin Cancer Res 1999; 10 Suppl.: 3124\u201338","journal-title":"Clin Cancer Res"},{"key":"BF03256607_CR17","first-page":"2081","volume":"40","author":"M Jong de","year":"1999","unstructured":"de Jong M, Bakker WH, Bernard BF, et al. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analogue: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy. J Nucl Med 1999; 40: 2081\u20137","journal-title":"J Nucl Med"},{"key":"BF03256607_CR18","first-page":"1029","volume":"40","author":"TM Behr","year":"1999","unstructured":"Behr TM, Jenner N, Behe M, et al. Radiolabelled peptides for targeting cholecystokinin-B\/gastrin receptor expressing tumors. J Nucl Med 1999; 40: 1029\u201344","journal-title":"J Nucl Med"},{"key":"BF03256607_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000049163","volume":"47","author":"KJ O\u2019Byrne","year":"2001","unstructured":"O\u2019Byrne KJ, Schally AV, Thomas A, et al. Somatostatin, its receptors and analogs, in lung cancer. Chemotherapy, 2001; 47: 78\u2013108","journal-title":"Chemotherapy"},{"key":"BF03256607_CR20","first-page":"224","volume":"39","author":"I Reisinger","year":"1998","unstructured":"Reisinger I, Bohuslavitzki KH, Brenner W, et al. Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study. J Nucl Med 1998; 39: 224\u20137","journal-title":"J Nucl Med"},{"key":"BF03256607_CR21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00003072-199712000-00001","volume":"22","author":"MMH Hochenstenbag","year":"1997","unstructured":"Hochenstenbag MMH, Heidendal GAK, Wouters EFM, et al. In-111 octreotide imaging in small cell lung cancer. Clin Nucl Med 1997; 22: 811\u20136","journal-title":"Clin Nucl Med"},{"key":"BF03256607_CR22","first-page":"847","volume":"10","author":"G Buccheri","year":"1997","unstructured":"Buccheri G, Ferrigno D, Biggi A. Nuclear medicine in lung cancer: a plenty of possibilities. Int J Oncol 1997; 10: 847\u201355","journal-title":"Int J Oncol"},{"key":"BF03256607_CR23","first-page":"1106","volume":"10","author":"DJ Kwekkeboom","year":"1994","unstructured":"Kwekkeboom DJ, Kho GS, Lamberts SWJ, et al. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994; 10: 1106\u201313","journal-title":"Eur J Nucl Med"},{"key":"BF03256607_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1742-1241.1995.tb09964.x","volume":"49","author":"MPM Stokkel","year":"1995","unstructured":"Stokkel MPM, Kwa BM, Pauwels EJK. Imaging and staging of small cell lung cancer: is there a role for octreotide scintigraphy. Br J Clin Pract 1995; 49: 235\u20138","journal-title":"Br J Clin Pract"},{"key":"BF03256607_CR25","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1378\/chest.117.5.1232","volume":"117","author":"J Blum","year":"2000","unstructured":"Blum J, Handmaker H, Lister-James J, et al. A multicentre trial with somatostatin analog Tc-99m depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117: 1232\u20138","journal-title":"Chest"},{"key":"BF03256607_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0196-9781(99)00202-8","volume":"21","author":"R Busto","year":"2000","unstructured":"Busto R, Prieto JC, Bodega G, et al. Immunohistochemical localization and distribution of VIP\/PACAP receptors in human lung. Peptides 2000; 21: 265\u20139","journal-title":"Peptides"},{"key":"BF03256607_CR27","first-page":"1846","volume":"36","author":"JC Reubi","year":"1995","unstructured":"Reubi JC. In-vitro identification of vasoactive-intestinal-peptide receptors in human tumors-implications for tumor imaging. J Nucl Med 1995; 36: 1846\u201353","journal-title":"J Nucl Med"},{"key":"BF03256607_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1998.433","volume":"78","author":"M Raderer","year":"1998","unstructured":"Raderer M, Kurturan A, Hejna M, et al. I-123-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer. Br J Cancer 1998; 78: 1\u20135","journal-title":"Br J Cancer"},{"key":"BF03256607_CR29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2362.1997.1990742.x","volume":"27","author":"I Virgolini","year":"1997","unstructured":"Virgolini I. Mack Forster Award Lecture-Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients. Eur J Clin Invest 1997; 27: 793\u2013800","journal-title":"Eur J Clin Invest"},{"key":"BF03256607_CR30","first-page":"1570","volume":"39","author":"M Raderer","year":"1998","unstructured":"Raderer M, Kurturan A, Yang Q, et al. Iodine-123-vasoactive intestinal peptide receptor scanning in patients with pancreatic cancer. J Nucl Med 1998; 39: 1570\u20135","journal-title":"J Nucl Med"},{"key":"BF03256607_CR31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0969-8051(96)00066-2","volume":"23","author":"I Virgolini","year":"1996","unstructured":"Virgolini I, Raderer M, Kurturan A, et al. I-123-vasoactive intestinal peptide (VIP) receptor scanning: update of imaging results in patients with adenocarcinomas and endocrine tumours of the gastrointestinal tract. Nucl Med Biol 1996; 23: 685\u201392","journal-title":"Nucl Med Biol"},{"key":"BF03256607_CR32","first-page":"107","volume":"41","author":"ML Thakur","year":"2000","unstructured":"Thakur ML, Marcus CS, Saeed S, et al. 99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans. J Nucl Med 2000; 41: 107\u201310","journal-title":"J Nucl Med"},{"key":"BF03256607_CR33","first-page":"1850","volume":"7","author":"J Brabender","year":"2001","unstructured":"Brabender J, Danenberg KD, Metzger R, et al. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res 2001; 7: 1850\u20135","journal-title":"Clin Cancer Res"},{"key":"BF03256607_CR34","first-page":"768","volume":"40","author":"M Ramos-Suzarte","year":"1999","unstructured":"Ramos-Suzarte M, Rodriguez N, Olivia JP, et al. Tc-99m-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: part III. Clinical trials, safety and diagnostic efficacy. J Nucl Med 1999; 40: 768\u201375","journal-title":"J Nucl Med"},{"key":"BF03256607_CR35","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1097-0142(19940201)73:3+<884::AID-CNCR2820731320>3.0.CO;2-U","volume":"73","author":"S Dadparvar","year":"1994","unstructured":"Dadparvar S, Krishna L, Miyamoto C, et al. Indium-111-labeled anti-EGFR-425 scintigraphy in the detection of malignant gliomas. Cancer 1994; 73: 884\u20139","journal-title":"Cancer"},{"key":"BF03256607_CR36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002620050259","volume":"42","author":"S R Senekowitsch","year":"1996","unstructured":"Senekowitsch Schmidtke R, Steiner K, Haunschild J, et al. In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumour xenografts using radiolabeled EGF and anti-(EGF receptor) mAB 425. Cancer Immunol Immunother 1996; 42: 108\u201314","journal-title":"Cancer Immunol Immunother"},{"key":"BF03256607_CR37","first-page":"654","volume":"103","author":"N Pateisky","year":"1991","unstructured":"Pateisky N, Schatten C, Vavra N, et al. Lymphoscintigraphy using epidermal growth-factor as tumor-seeking agent in uterine cervical cancer. Wien Klin Wochenschr 1991; 103: 654\u20136","journal-title":"Wien Klin Wochenschr"},{"key":"BF03256607_CR38","first-page":"429","volume":"41","author":"RM Reilly","year":"2000","unstructured":"Reilly RM, Kiarash R, Cameron R, et al. In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl Med 2000; 41: 429\u201338","journal-title":"J Nucl Med"},{"key":"BF03256607_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1011192622688","volume":"12","author":"S Scholl","year":"2001","unstructured":"Scholl S, Beuzeboc P, Pouillart P. Targeting HER2 in other tumor types. Ann Oncol 2001; 12 Suppl.: 81\u20137","journal-title":"Ann Oncol"},{"key":"BF03256607_CR40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJM200109273451312","volume":"345","author":"TM Behr","year":"2001","unstructured":"Behr TM, Behe M, Wormann B. Trastuzumab and breast cancer. N Engl J Med 2001; 345: 995\u20136","journal-title":"N Engl J Med"},{"key":"BF03256607_CR41","first-page":"2753","volume":"236","author":"The PIOPED Investigators","year":"1990","unstructured":"The PIOPED Investigators. Value of the ventilation\/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990; 236: 2753\u20139","journal-title":"JAMA"},{"key":"BF03256607_CR42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002590050016","volume":"27","author":"J Blum","year":"2000","unstructured":"Blum J. Receptor radiopharmaceuticals: biomolecular medicine. Eur J Nucl Med 2000; 27: 121\u20132","journal-title":"Eur J Nucl Med"},{"key":"BF03256607_CR43","first-page":"155","volume":"17","author":"K Missy","year":"2001","unstructured":"Missy K, Giuriato S, Bodin S, et al. Integrins and signal transduction: illustration with the alpha(IIb)beta(3) integrin in platelets. Med Sci 2001; 17: 155\u201361","journal-title":"Med Sci"},{"key":"BF03256607_CR44","first-page":"1214","volume":"41","author":"R Taillefer","year":"2000","unstructured":"Taillefer R, Edell S, Innes G, et al. Acute thromboscintigraphy with Tc-99m-apcitide: results of the phase 3 multicentre clinical trial comparing Tc-99m-apcitide scintigraphy with contrast venography for imaging acute DVT. J Nucl Med 2000; 41: 1214\u201323","journal-title":"J Nucl Med"},{"key":"BF03256607_CR45","first-page":"111","volume":"41","author":"J Lister-James","year":"1997","unstructured":"Lister-James J, Moyer BR, Dean RT. Pharmacokinetic considerations in the development of peptide-based imaging agents. Q J Nucl Med 1997; 41: 111\u20138","journal-title":"Q J Nucl Med"},{"key":"BF03256607_CR46","first-page":"64P","volume":"39","author":"V Pallela","year":"1998","unstructured":"Pallela V, Consigny PM, Shi R, et al. Imaging vascular thrombosis with Tc-99-TP-1300 peptide derived from active domain of thrombospondin (TSP) [abstract]. J Nucl Med 1998; 39: 64P","journal-title":"J Nucl Med"},{"key":"BF03256607_CR47","first-page":"282","volume":"35","author":"LC Knight","year":"1994","unstructured":"Knight LC, Radcliffe R, Maurer AH, et al. Thrombus imaging with Tc-99m synthetic peptides based upon the binding domain of a monoclonal-antibody to activated platelets. J Nucl Med 1994; 35: 282\u20138","journal-title":"J Nucl Med"},{"key":"BF03256607_CR48","first-page":"1056","volume":"41","author":"LC Knight","year":"2000","unstructured":"Knight LC, Baidoo KE, Romano JE, et al. Imaging pulmonary emboli and deep venous thrombi with 99mTc-bitistatin, a platelet-binding polypeptide from viper venom. J Nucl Med 2000; 41: 1056\u201364","journal-title":"J Nucl Med"},{"key":"BF03256607_CR49","first-page":"18P","volume":"38","author":"JA Barrett","year":"1997","unstructured":"Barrett JA, Crocker A, Hemingway S, et al. DMP444, a technetium-labelled platelet GPIIb\/IIIa antagonist for the detection of arterial thrombi [abstract]. J Nucl Med 1997; 38: 18P","journal-title":"J Nucl Med"},{"issue":"3","key":"BF03256607_CR50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/snuc.2000.7441","volume":"30","author":"O Boerman","year":"2000","unstructured":"Boerman O, Oyen WJG, Corstens FHM. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. Semin Nucl Med 2000; 30(3): 195\u2013208","journal-title":"Semin Nucl Med"},{"key":"BF03256607_CR51","first-page":"1621","volume":"34","author":"JR Buscombe","year":"1993","unstructured":"Buscombe JR, Oyen WJ, Grant A, et al. Indium-111-labeled polyclonal human immunoglobulin: identifying focal infection in patients positive for human immunodeficiency virus. J Nucl Med 1993; 34: 1621\u20135","journal-title":"J Nucl Med"},{"key":"BF03256607_CR52","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/BF00181072","volume":"21","author":"JR Buscombe","year":"1994","unstructured":"Buscombe JR, Khalkhali I, Mason GR, et al. Indium-111 labelled pooled human immunoglobulin imaging to monitor the efficacy of specific therapy for Pneumocystis carinii pneumonia. Eur J Nucl Med 1994; 21: 1148\u201350","journal-title":"Eur J Nucl Med"},{"key":"BF03256607_CR53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00006231-199505000-00003","volume":"16","author":"JR Buscombe","year":"1995","unstructured":"Buscombe JR, Oyen WJ, Corstens FH, et al. A comparison of 111In-HIG scintigraphy and chest radiology in the identification of pulmonary infection in patients with HIV infection. Nucl Med Commun 1995; 16: 327\u201335","journal-title":"Nucl Med Commun"},{"key":"BF03256607_CR54","first-page":"212","volume":"39","author":"JR Buscombe","year":"1995","unstructured":"Buscombe JR, Oyen WJ, Corstens FH. Use of polyclonal IgG in HIV infection and AIDS. J Nucl Med 1995; 39: 212\u201320","journal-title":"J Nucl Med"},{"key":"BF03256607_CR55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF01254565","volume":"22","author":"W Calame","year":"1995","unstructured":"Calame W, Welling M, Feitsma HI, et al. Contribution of phagocytic cells and bacteria to the accumulation of technetium-99m labelled polyclonal human immunoglobulin at sites of inflammation. Eur J Nucl Med 1995; 22: 638\u201344","journal-title":"Eur J Nucl Med"},{"key":"BF03256607_CR56","first-page":"1538","volume":"30","author":"EM Morrel","year":"1989","unstructured":"Morrel EM, Tompkins RG, Fischman AH, et al. Autoradiographic method for quantitation of radiolabelled proteins in tissues using indium-111. J Nucl Med 1989; 30: 1538\u201345","journal-title":"J Nucl Med"},{"key":"BF03256607_CR57","first-page":"1199","volume":"31","author":"AJ Fischman","year":"1990","unstructured":"Fischman AJ, Rubin RH, White JA, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 1990; 31: 1199\u2013205","journal-title":"J Nucl Med"},{"key":"BF03256607_CR58","first-page":"359","volume":"49","author":"P Diot","year":"1992","unstructured":"Diot P, LePape A, Nolibe D, et al. Scintigraphy with J001X, a Klebsiella membrane glycolipid, for the early diagnosis of chronic berilliosis: results from an experimental model. Br J Ind Med 1992; 49: 359\u201364","journal-title":"Br J Ind Med"},{"key":"BF03256607_CR59","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/thx.49.5.504","volume":"49","author":"P Diot","year":"1994","unstructured":"Diot P, Diot E, Lemarie E, et al. Imaging of pulmonary disease in scleroderma with J001X scintigraphy. Thorax 1994; 49: 504\u20138","journal-title":"Thorax"},{"key":"BF03256607_CR60","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/BF01791150","volume":"22","author":"P Goupille","year":"1995","unstructured":"Goupille P, Diot P, Valat JP, et al. Imaging of pulmonary disease in rheumatoid arthritis using J001X scintigraphy: preliminary results. Eur J Nucl Med 1995; 22: 1411\u20135","journal-title":"Eur J Nucl Med"},{"key":"BF03256607_CR61","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s002590050297","volume":"25","author":"DJ Kwekkeboom","year":"1998","unstructured":"Kwekkeboom DJ, Krenning EP, Kho GS, et al. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 1998; 25: 1284\u201392","journal-title":"Eur J Nucl Med"},{"key":"BF03256607_CR62","first-page":"497","volume":"21","author":"P Hagen Van","year":"1994","unstructured":"Van Hagen P, Krenning E, Reubi J, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994; 21: 497\u2013502","journal-title":"Eur J Nucl Med"}],"container-title":["American Journal of Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03256607\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T11:40:01Z","timestamp":1687693201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03256607"}},"subtitle":["Advances in the Diagnosis of Pulmonary Diseases"],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["BF03256607"],"URL":"https:\/\/doi.org\/10.1007\/bf03256607","relation":{},"ISSN":["1175-6365"],"issn-type":[{"value":"1175-6365","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}